Literature DB >> 2889461

The effect of famotidine on renal function in patients with renal insufficiency.

P A Abraham1, J A Opsahl, C E Halstenson, A N Chremos, G R Matzke, W F Keane.   

Abstract

The effect of famotidine, a new histamine H2-receptor antagonist, on renal tubular creatinine secretion was evaluated in twelve patients with reduced renal function (creatinine clearance 10-60 ml min-1). Creatinine and inulin clearances were determined at baseline and for 4 h after a 10 mg intravenous dose of famotidine. Famotidine renal clearance exceeded inulin clearance by an average of 152%, indicating that renal tubular secretion of famotidine occurred. No significant changes in the clearances of creatinine or inulin, or the fractional clearance of creatinine were observed after famotidine administration. These data suggest that famotidine, unlike cimetidine, does not inhibit renal tubular secretion of creatinine. Thus, famotidine does not affect creatinine-dependent measurements of renal function and is unlikely to alter the renal elimination of basic drugs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889461      PMCID: PMC1386262          DOI: 10.1111/j.1365-2125.1987.tb03185.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Inhibition of renal creatinine secretion by cimetidine in humans.

Authors:  E Burgess; A Blair; K Krichman; R E Cutler
Journal:  Ren Physiol       Date:  1982

Review 2.  Renal tubule transport of organic cations.

Authors:  B R Rennick
Journal:  Am J Physiol       Date:  1981-02

3.  Effect of cimetidine on renal function in normal man.

Authors:  J W Dubb; R M Stote; R G Familiar; K Lee; F Alexander
Journal:  Clin Pharmacol Ther       Date:  1978-07       Impact factor: 6.875

4.  Limitations of creatinine as a filtration marker in glomerulopathic patients.

Authors:  O Shemesh; H Golbetz; J P Kriss; B D Myers
Journal:  Kidney Int       Date:  1985-11       Impact factor: 10.612

5.  Cimetidine and procainamide secretion by proximal tubules in vitro.

Authors:  T D McKinney; K V Speeg
Journal:  Am J Physiol       Date:  1982-06

6.  Cimetidine-procainamide pharmacokinetic interaction in man: evidence of competition for tubular secretion of basic drugs.

Authors:  A Somogyi; A McLean; B Heinzow
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  The effects of cimetidine (Tagamet) on renal function in patients with renal failure.

Authors:  R Larsson; G Bodemar; B Kågedal; A Walan
Journal:  Acta Med Scand       Date:  1980

8.  Tubular transport and metabolism of cimetidine in chicken kidneys.

Authors:  B Rennick; J Ziemniak; I Smith; M Taylor; M Acara
Journal:  J Pharmacol Exp Ther       Date:  1984-02       Impact factor: 4.030

9.  Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion.

Authors:  M J Collen; J M Howard; K E McArthur; J P Raufman; M J Cornelius; C A Ciarleglio; J D Gardner; R T Jensen
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

10.  Ranitidine compared with cimetidine in the short-term healing of duodenal ulcer.

Authors:  F I Lee; J D Fielding; F T Costello
Journal:  Postgrad Med J       Date:  1983-02       Impact factor: 2.401

View more
  7 in total

Review 1.  Haematological adverse effects of histamine H2-receptor antagonists.

Authors:  J P Aymard; B Aymard; P Netter; B Bannwarth; P Trechot; F Streiff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

Review 2.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

3.  Pharmacokinetics of famotidine in elderly patients with and without renal insufficiency and in healthy young volunteers.

Authors:  N Inotsume; M Nishimura; S Fujiyama; K Sagara; T Sato; Y Imai; H Matsui; M Nakano
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 4.  Newer H2-receptor antagonists. Clinical pharmacokinetics and drug interaction potential.

Authors:  D R Krishna; U Klotz
Journal:  Clin Pharmacokinet       Date:  1988-10       Impact factor: 6.447

Review 5.  Renal effects of peptic ulcer therapy.

Authors:  E Burgess; D Muruve
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

Review 6.  Clinical pharmacokinetics of famotidine.

Authors:  H Echizen; T Ishizaki
Journal:  Clin Pharmacokinet       Date:  1991-09       Impact factor: 6.447

7.  Physiologically-Based Pharmacokinetic Modelling of Creatinine-Drug Interactions in the Chronic Kidney Disease Population.

Authors:  Hiroyuki Takita; Daniel Scotcher; Rajkumar Chinnadurai; Philip A Kalra; Aleksandra Galetin
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-11-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.